Investors should monitor key support levels at $23 and $13, along with resistance levels at $36 and $68 for Moderna (MRNA) shares. The recent resignation of FDA's top vaccine official may impact the stock, which has fallen significantly this year.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay